文献速递眼底病与葡萄膜炎眼整形与眼眶

脉络膜黑色素瘤质子治疗后的剂量-反应与正常组织并发症概率

Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma.
PubMed 文献 · Ophthalmology · 2020-06-20

该回顾性研究基于法国尼斯单中心1020例接受低分割质子治疗(52 Gy物理剂量分4次)的脉络膜黑色素瘤患者,采用LASSO变量选择及多变量Cox和逻辑回归建立正常组织并发症概率模型。研究发现视力恶化与黄斑近最大剂量相关性最强,而特定晚期并发症与特定结构的剂量指标相关。

要点

  • 黄斑近最大剂量与视力恶化相关性最强。
  • 视网膜近最大剂量是黄斑病变的唯一显著影响变量。
  • 视盘20%剂量、角膜20%剂量、睫状体20%剂量分别对视神经病变、新生血管性青光眼、眼高压影响最大。

核心结论

  • 质子治疗后视力恶化和特定晚期并发症均显示依赖于眼内正常结构接受的剂量。
  • 视力恶化依赖多个结构的剂量,而更特定的并发症与特定结构的剂量指标相关。

研究设计与样本

  • 单中心大转诊中心回顾性研究,纳入法国尼斯诊断为脉络膜黑色素瘤并主要接受低分割质子治疗(52 Gy物理剂量分4次)的患者。
  • 视力恶化完整信息可用者1020例,晚期并发症完整信息可用者991例。
  • 使用LASSO变量选择识别对各终点影响最强的变量,随后用多变量Cox回归和逻辑回归分析剂量、临床特征与临床结局的关系。

主要发现

  • 多个结构(视盘、黄斑、视网膜、眼球、晶状体、睫状体)的剂量指标与临床结局相关。
  • 黄斑近最大剂量与视力恶化相关性最强。
  • 视网膜近最大剂量是唯一对黄斑病变风险有明确影响的变量。
  • 视盘20%剂量对视神经病变影响最大,角膜20%剂量对新生血管性青光眼影响最大,睫状体20%剂量对眼高压影响最大。
  • 睫状体接受26 Gy的体积是唯一与白内障风险相关的变量,视网膜接受52 Gy的体积与视网膜脱离风险相关;无泪腺DVH时,视盘至肿瘤距离是唯一与干眼综合征相关的变量。

关键数值与推荐

  • 质子治疗剂量为52 Gy物理剂量分4次。
  • 睫状体接受26 Gy的体积与白内障风险相关。
  • 视网膜接受52 Gy的体积与视网膜脱离风险相关。

临床怎么用

  • NTCP模型可帮助理解保眼放疗后放射性毒性的剂量依赖性。
  • 利用特定结构的剂量指标(如黄斑近最大剂量、视盘20%剂量、角膜20%剂量、睫状体20%剂量)评估视力恶化和晚期并发症风险。
  • 关注睫状体V26Gy和视网膜V52Gy以评估白内障和视网膜脱离风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Normal tissue complication probability (NTCP) models could aid the understanding of dose dependence of radiation-induced toxicities after eye-preserving radiotherapy of choroidal melanomas. We performed NTCP-modeling and established dose-response relationships for visual acuity (VA) deterioration and common late complications after treatments with proton therapy (PT). DESIGN: Retrospective study from single, large referral center. PARTICIPANTS: We considered patients from Nice, France, diagnosed with choroidal melanoma and treated primarily with hypofractionated PT (52 Gy physical dose in 4 fractions). Complete VA deterioration information was available for 1020 patients, and complete information on late complications was available for 991 patients. METHODS: Treatment details, dose-volume histograms (DVHs) for relevant anatomic structures, and patient and tumor characteristics were available from a dedicated ocular database. Least absolute shrinkage and selection operator (LASSO) variable selection was used to identify variables with the strongest impact on each end point, followed by multivariate Cox regressions and logistic regressions to analyze the relationships among dose, clinical characteristics, and clinical outcomes. MAIN OUTCOME MEASURES: Dose-response relationship for VA deterioration and late complications. RESULTS: Dose metrics for several structures (i.e., optic disc, macula, retina, globe, lens, ciliary body) correlated with clinical outcome. The near-maximum dose to the macula showed the strongest correlation with VA deterioration. The near-maximum dose to the retina was the only variable with clear impact on the risk of maculopathy, the dose to 20% of the optic disc had the largest impact on optic neuropathy, dose to 20% of cornea had the largest impact on neovascular glaucoma, and dose to 20% of the ciliary body had the largest impact on ocular hypertension. The volume of the ciliary body receiving 26 Gy was the only variable associated with the risk of cataract, and the volume of retina receiving 52 Gy was associated with the risk of retinal detachment. Optic disc-to-tumor distance was the only variable associated with dry eye syndrome in the absence of DVH for the lachrymal gland. CONCLUSIONS: VA deterioration and specific late complications demonstrated dependence on dose delivered to normal structures in the eye after PT for choroidal melanoma. VA deterioration depended on dose to a range of structures, whereas more specific complications were related to dose metrics for specific structures.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Espensen CA, Kiilgaard JF, Appelt AL, et al. Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma. Ophthalmology. 2020. PMID: 32574763. doi:10.1016/j.ophtha.2020.06.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。